Elsevier Inc.

SHERPA: Unknown

People

  1. Yu
    Yu
  2. Foster
    Foster
  3. Patel
    Patel
  4. Riely
    Riely
  5. Rimner
    Rimner
  6. Woo
    Woo
  7. Wu
    Wu
  8. Zhang
    Zhang
  9. Gelblum
    Gelblum
  10. Gomez
    Gomez

Groups

  1. Department of Medicine (5)
  2. Radiation Oncology, Department of (5)
  3. Solid Tumor Oncology Division (5)
  4. Survivorship Research (5)
  5. Thoracic Oncology (5)
  6. Biostatistics Service (4)
  7. Epidemiology and Biostatistics (4)
  8. Surgery (4)
  9. GME, Radiation Oncology (1)
  10. Graduate Medical Education (1)
Search Within
  1. "Andreas Rimner"
  2. "Helena Yu"
  3. "International Journal of Radiation Oncology, Biology, Physics"
  4. "Survivorship Research"
Formats
  1. Meeting Abstract (5)
Groups
  1. Department of Medicine (5)
  2. Radiation Oncology, Department of (5)
  3. Solid Tumor Oncology Division (5)
  4. Survivorship Research (5)
  5. Thoracic Oncology (5)
  6. Biostatistics Service (4)

More Groups

People
  1. Andreas Rimner (5)
  2. Helena Yu (5)
  3. Abraham Wu (4)
  4. Amanda Foster (4)
  5. Gregory Riely (4)
  6. Kaitlin Woo (4)

More People

Years
  1. 2022 (1)
  2. 2014 (4)
Publications
  1. International Journal of Radiation Oncology, Biology, Physics (5)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Factors associated with outcomes in patients with metastatic NSCLC receiving osimertinib and consolidative radiation therapy
    Meeting Abstract

    Ma, J.; Yu, H.; Gelblum, D.; Kroen, E.; Shaverdian, N.; Tsai, C. J.; Yang, J. T.; Rimner, A.; Huang, J.; Gomez, D. R.
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Pattern of failure in metastatic EGFR-mutant NSCLC treated with erlotinib: A role for upfront radiation therapy?
    Meeting Abstract

    Patel, S.; Rimner, A.; Foster, A.; Zhang, Z.; Woo, K. M.; Yu, H. A.; Riely, G. J.; Wu, A. J.
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save
  • Risk of brain metastasis in EGFR-mutant NSCLC treated with erlotinib: A role for prophylactic cranial irradiation?
    Meeting Abstract

    Patel, S.; Rimner, A.; Foster, A.; Zhang, Z.; Woo, K. M.; Yu, H. A.; Riely, G. J.; Wu, A. J.
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save
  • Pattern of failure in metastatic EGFR-mutant NSCLC treated with erlotinib: A role for upfront radiation therapy?
    Meeting Abstract

    Patel, S.; Rimner, A.; Foster, A.; Zhang, Z.; Woo, K. M.; Yu, H. A.; Riely, G. J.; Wu, A. J.
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save
  • Risk of brain metastasis in EGFR-mutant NSCLC treated with erlotinib: A role for prophylactic cranial irradiation?
    Meeting Abstract

    Patel, S.; Rimner, A.; Foster, A.; Zhang, Z.; Woo, K. M.; Yu, H. A.; Riely, G. J.; Wu, A. J.
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save